1. Home
  2. GKOS vs VFC Comparison

GKOS vs VFC Comparison

Compare GKOS & VFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$141.22

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo V.F. Corporation

VFC

V.F. Corporation

HOLD

Current Price

$19.03

Market Cap

6.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
VFC
Founded
1998
1899
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.6B
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
GKOS
VFC
Price
$141.22
$19.03
Analyst Decision
Strong Buy
Hold
Analyst Count
12
18
Target Price
$126.92
$18.24
AVG Volume (30 Days)
642.1K
6.2M
Earning Date
04-29-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.72
EPS
N/A
0.95
Revenue
$507,442,000.00
$10,488,556,000.00
Revenue This Year
$23.32
N/A
Revenue Next Year
$27.43
$2.06
P/E Ratio
N/A
$19.98
Revenue Growth
32.33
N/A
52 Week Low
$73.16
$11.11
52 Week High
$145.50
$22.27

Technical Indicators

Market Signals
Indicator
GKOS
VFC
Relative Strength Index (RSI) 73.45 51.34
Support Level $80.14 $18.05
Resistance Level N/A $20.40
Average True Range (ATR) 4.95 0.85
MACD 1.69 -0.18
Stochastic Oscillator 86.28 24.04

Price Performance

Historical Comparison
GKOS
VFC

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About VFC V.F. Corporation

VF designs, produces, and distributes branded apparel, footwear, and accessories. Its apparel categories are active, outdoor, and work. Its portfolio of 10 brands includes Vans, The North Face, Timberland, and Altra. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. Tracing its roots to 1899, the company has evolved through many brand acquisitions and dispositions.

Share on Social Networks: